Vicore Pharma
Focus: Vicore Pharma is a Swedish public company focused on small-molecule therapeutics across respiratory, infectious disease, and metabolic disorders. The company operates at mid-stage development with a diversified pipeline centered on its lead asset C21.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Vicore Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Vicore Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
C21
COVID-19Clinical Trials (1)
NCT04878913Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
N/AHelp build intelligence for Vicore Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.